• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Efficacy and safety of recanalization therapy for acute ischemic stroke with COVID-19: A systematic review and meta-analysis
ConclusionsCompared with COVID-19 negative AIS patients who received recanalization treatments, COVID-19 positive patients turned out to have poorer outcomes. Particular attention needs to be paid to the treatments for these COVID-19 patients to decrease mortality and morbidity. Long-term follow-up is necessary to evaluate the recanalization treatments for AIS patients with COVID-19.Systematic review registrationhttps://inplasy.com/inplasy-2022-4-0022/, identifier: INPLASY202240022.
Source: Frontiers in Neurology - August 30, 2022 Category: Neurology Source Type: research

Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City
Discussion Hospitalized patients with SARS-CoV-2 and new neurologic diagnoses have significant morbidity and mortality postdischarge. Further research is needed to define the effect of neurologic diagnoses during acute hospitalization on longitudinal post-COVID-19–related symptoms including neurocognitive impairment.
Source: Neurology Clinical Practice - August 9, 2022 Category: Neurology Authors: Thakur, K. T., Chu, V. T., Hughes, C., Kim, C. Y., Fleck-Derderian, S., Barrett, C. E., Matthews, E., Balbi, A., Bilski, A., Chomba, M., Lieberman, O., Jacobson, S. D., Agarwal, S., Roh, D., Park, S., Ssonko, V., Silver, W. G., Vargas, W. D., Geneslaw, A. Tags: Research Article Source Type: research

Stroke admissions during the COVID-19 pandemic: a single-center retrospective analysis
ConclusionThese findings reflect changing patient attitudes during the COVID-19 pandemic or the success of health system and public health campaigns to reassure patients about the safety of seeking emergency care when needed, not only for more severe stroke symptoms.
Source: Neurological Sciences - June 20, 2022 Category: Neurology Source Type: research

Comparison of disease profiles and three-month outcomes of patients with neurological disorders with and without COVID-19: An ambispective cohort study
Conclusion: Patients with neurological disorders presenting with COVID-19 infection had worse outcomes, including in-hospital and 3 months disability.
Source: Annals of Indian Academy of Neurology - May 25, 2022 Category: Neurology Authors: Kanchana S Pillai Deepti Vibha Pranjal Gupta Pachipala Sudheer Biswamohan Mishra Rahul S Oinam Ayush Mohan Kamalesh Tayade Padma Srivastava Manjari Tripathi Achal K Srivastava Rohit Bhatia Roopa Rajan Awadh K Pandit Rajesh K Singh Arunmozhimaran Elavarasi Source Type: research

Opioid-Use, COVID-19 Infection, and Their Neurological Implications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an imminent threat to human health and public safety. ACE2 and transmembrane serine protease 2 proteins on host cells provide the viral entry point to SARS-CoV-2. Although SARS-CoV-2 mainly infects the respiratory system, there have been reports of viral neurotropism and central nervous system injury as indicated by plasma biomarkers, including neurofilament light chain protein and glial fibrillary acidic protein. Even with a small proportion of infections leading to neurological manifestation, the overall number remains high. Common neurological manifestation...
Source: Frontiers in Neurology - May 23, 2022 Category: Neurology Source Type: research

Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature
Conclusion: Our study points out that, in addition to cerebral venous thrombosis, adenoviral vector-based vaccines also appear to have a cerebral arterial thrombotic risk, and clinicians should be aware that ischemic stroke with LVO, although rare, could represent a clinical presentation of VITT.Cerebrovasc Dis
Source: Cerebrovascular Diseases - May 5, 2022 Category: Neurology Source Type: research

Large Vessel Occlusions By Free Floating Thrombi in Strokes During the COVID-19 pandemic- A Single Center Observational Study
Conclusions: This study highlights the presence of FFT causing LVO as a new stroke subtype during the COVID-19 pandemic. With renewed and steeper spike in COVID-19 cases, especially new variants, the resurgence of this stroke subtype needs to be actively explored early in the course of illness to reduce morbidity and mortality.
Source: Neurology India - May 3, 2022 Category: Neurology Authors: Samhita Panda Sarbesh Tiwari Jaya Pamnani Monalisa Vegda Apoorv Patel Sanjiv Sharma Saksham Jain Pratik Patel Deepika Saroha Pushpinder Khera Naresh Midha Mayank Garg Vijaya Lakshmi Nag Source Type: research

Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria
CONCLUSION: GBS is a frequent autoimmune neuropathy that has been associated with preceding infections and with vaccination campaigns. For SARS-CoV-2 vaccination campaign in Mexico, validation of Brighton Criteria is necessary. Although Mexico's GBS epidemiology has been changing throughout recent years, this study provides similar data compared to other countries.PMID:35383873 | DOI:10.33588/rn.7408.2021437
Source: Revista de Neurologia - April 6, 2022 Category: Neurology Authors: J C L ópez-Hernández J A Galnares-Olalde A Guti érrez S A Estrada M Garc ía-Grimshaw E S Vargas-Ca ñas Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13